LIGAND PHARM Price Prediction and Hype Density Breakdown

LGNXZ -- USA Stock  

USD 0.05  0.01  16.67%

We analyze noise-free headlines and recent hype associated with LIGAND PHARM INC which may create opportunities for some arbitrage if properly timed. With LIGAND PHARM hype-based prediction module you can estimate the value of LIGAND PHARM INC from the prospective of LIGAND PHARM response to recently generated media hype and the effects of current headlines on its competitors. The module also provides analysis of price elasticity to changes in media outlook on LIGAND PHARM over a specific investment horizon. Please see also LIGAND PHARM Basic Forecasting Models to cross-verify your projections.
Horizon     30 Days    Login   to change

LIGAND PHARM Estimiated After-Hype Price Volatility

 Next price density 
Expected price to next headline

LIGAND PHARM Next Price Analysis

Daily Expected returnPeriod VolatilityHype elasticityRelated hype elasticityAverage news densityRelated news densityNext Expected Hype
 3.29% 15.14% 0.00%  175.58% 0 Events / Month6 Events / MonthUncertain
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility

LIGAND PHARM Hype Timeline

LIGAND PHARM INC is now traded for0.05. This company stock is not elastic to its hype. The average elasticity to hype of competition is -175.58. LIGAND PHARM INC is anticipated not to react to the next headline with price going to stay at about the same level and average media hype impact volatility of 0.0%. The immediate return on the next news is anticipated to be very small where as daily expected return is now at -3.29%. The volatility of relative hype elasticity to LIGAND PHARM is about 28.37%%. The volatility of related hype on LIGAND PHARM is about 28.37% with expected price after next announcement by competition of -175.53. The company had not issued any dividends in recent years. Assuming 30 trading days horizon, the next anticipated press release will be uncertain.
Please see also LIGAND PHARM Basic Forecasting Models to cross-verify your projections.

LIGAND PHARM Related Hype Analysis

At Risk
Amazon(46.70) 6 per month 2.30 (0.0253)  4.13 (3.27)  8.52 
Vedanta Limited 6.80 7 per month 1.11  0.09  3.96 (2.31)  7.68 
Hero MotoCorp Limited 23.95 1 per month 0.00 (0.19)  1.37 (2.36)  8.74 
CHINA LIFE INSURANCE LTD(0.12) 2 per month 0.00 (0.16)  2.67 (2.69)  4.61 
Megaworld Corporation 0.00 0 per month 0.00 (0.11)  8.38 (9.30)  13.97 
Metro Pacific Investments Corporation 0.00 4 per month 0.00  0.12  0.67  0.00  7.90 
HSBC Holdings plc(0.1) 5 per month 0.00 (0.58)  0.31 (0.54)  1.91 
Berkshire Hathaway(465.00) 6 per month 0.00  0.11  1.39 (0.62)  2.27 
Berkshire Hathaway 0.87 5 per month 0.00  0.10  1.22 (0.72)  2.72 

Latest Stories

Recently Published Macroaxis Stories

Investors are also interested in

Purchased a lot of shares
Active 3 days ago
Purchased a lot of shares
Active 3 days ago
Please see also LIGAND PHARM Basic Forecasting Models to cross-verify your projections. Please also try Piotroski F Score module to get piotroski f score based on binary analysis strategy of nine different fundamentals.